A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype

Experimental Neurology
Kirk NylenO C Snead

Abstract

Succinic semialdehyde dehydrogenase (SSADH) deficiency is a heritable disorder of GABA degradation characterized by ataxia, psychomotor retardation and seizures. To date, there is no effective treatment for SSADH deficiency. We tested the hypothesis that a ketogenic diet (KD) would improve outcome in an animal model of SSADH deficiency, the SSADH knockout mouse (Aldh5a1-/-). Using a 4:1 ratio of fat to combined carbohydrate and protein KD we set out to compare the general phenotype, in vivo and in vitro electrophysiology and [35S]TBPS binding in both Aldh5a1-/- mice and control (Aldh5a1+/+) mice. We found that the KD prolonged the lifespan of mutant mice by >300% with normalization of ataxia, weight gain and EEG compared to mutants fed a control diet. Aldh5a1-/- mice showed significantly reduced mIPSC frequency in CA1 hippocampal neurons as well as significantly decreased [35S]TBPS binding in all brain areas examined. In KD fed mutants, mIPSC activity normalized and [35S]TBPS binding was restored in the cortex and hippocampus. The KD appears to reverse toward normal the perturbations seen in Aldh5a1-/- mice. Our data suggest that the KD may work in this model by restoring GABAergic inhibition. These data demonstrate a successfu...Continue Reading

References

Jan 1, 1969·International Anesthesiology Clinics·M D Vickers
Sep 15, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·K M GibsonF Hanefeld
Dec 10, 1999·Epilepsy Research·E P Vining
Dec 10, 1999·Neuropharmacology·K LingenhoehlJ Mosbacher
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Maneesh GuptaK Michael Gibson
Oct 17, 2002·The Journal of Physiology·Jonathon P Wetherington, Nevin A Lambert
Nov 29, 2002·Developmental Medicine and Child Neurology·Eileen P G ViningJohn M Freeman
Apr 19, 2003·Epilepsia·A G Christina BergqvistVirginia A Stallings
Jun 5, 2003·Journal of the American Dietetic Association·Yeou-Mei Christiana LiuRosalind Curtis
Aug 2, 2003·Annals of Neurology·Sergei S LikhodiiW McIntyre Burnham
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Peter O KwiterovichJohn M Freeman
Oct 16, 2003·Nutrition·Hussein M DashtiNaji S Al-Zaid
Jan 9, 2004·Pediatric Research·Qian ZhaoGregory L Holmes
Feb 11, 2004·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Jörg KlepperThomas Voit
Jun 23, 2004·Lancet Neurology·Eric H Kossoff
Sep 3, 2004·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Neil Gordon
Dec 8, 2004·Pharmacology, Biochemistry, and Behavior·M A CortezO C Snead
Jan 31, 2006·The British Journal of Nutrition·D PapandreouI Mavromichalis
Feb 25, 2006·The Journal of Comparative Neurology·Catherine Croft SwanwickJaideep Kapur
Apr 4, 2006·Nature Neuroscience·Kenichi N HartmanVenkatesh N Murthy
May 2, 2006·Brain Research·Andrea BuzziO Carter Snead
Aug 31, 2006·Behavioural Pharmacology·Maciej GasiorAdam L Hartman

❮ Previous
Next ❯

Citations

Jan 28, 2009·Journal of Inherited Metabolic Disease·P L PearlW H Theodore
Dec 31, 2011·The Journal of Biological Chemistry·William F SchwindingerJanet D Robishaw
Jun 24, 2010·Experimental Neurology·Irina VardyaKimmo Jensen
Dec 19, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·G Iglesias EscaleraC Pérez-Cerdá
Apr 1, 2008·Experimental Neurology·Ina Knerr, Phillip L Pearl
Aug 26, 2014·Amino Acids·Eloy Bejarano, José Antonio Rodríguez-Navarro
Jan 6, 2015·Developmental Medicine and Child Neurology·Phillip L PearlK Michael Gibson
Jun 26, 2015·Journal of Inherited Metabolic Disease·S Scholl-BürgiD Karall
May 9, 2014·Frontiers in Neurology·Carmela GiordanoGiuseppe Biagini
Jul 30, 2014·Frontiers in Pediatrics·Eleonora NapoliCecilia Giulivi
Oct 19, 2017·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Abbi R HernandezSara N Burke
Feb 26, 2020·Cells·Miroslava DidiášováRitva Tikkanen
Jul 6, 2019·Clinical Pharmacology and Therapeutics·Trevor O KirbyK Michael Gibson
Jul 13, 2020·Journal of Inherited Metabolic Disease·Cezar Gavrilovici, Jong M Rho
Jun 24, 2019·BMC Neurology·Cherubino Di LorenzoFrancesco Pierelli
May 27, 2015·Physiological Reports·J Harry BlaiseSusan A Masino
Mar 9, 2017·Frontiers in Molecular Neuroscience·Ning ChengSusan A Masino
Jan 5, 2021·Journal of Child Neurology·Phillip L PearlK Michael Gibson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.